Highlights from the GMP market and Valicare
You want to know what is driving the industry and ourselves? We have compiled the recent news for you here.
You want to know what is driving the industry and ourselves? We have compiled the recent news for you here.
ICH Q2(R2) and ICH Q14 describe mandatory requirements for the development, life cycle and validation of analytical methods.
Valicare experts present solutions to you Per- und Polyfluoroalkyl substances (PFAS) are widely used in the pharmaceutical and biotech industry as ...
Get an overview about the most important upcoming changes The revision of Annex 1 of the EU GMP Guideline will be effective this year. It faces ...
Working with highly active and hazardous drugs and ingredients requires evidence that the used containment systems are leak proof!
2nd Edition of the GAMP 5 Guideline will address required changes in computerized system validation (CSV). Have you adopted the changes yet?
Analytical procedure development: harmonization, development process as well as improvement of change management, approval and communication with ...
Innovations in the implementation of risk management in the pharmaceutical industry: product availability, hazard identification, and attention to ...
WHO publishes decision on setting acceptance criteria for cleaning validation
New ECA guide helps saving time and money by customer-supplier partnership on qualification and validation.
EMA strongly requests the risk-based proof that active substances and finished medicinal products are free of nitrosamines. Are you prepared for this?
The globally recognized standard for the classification of cleanrooms is "ISO 14644 – cleanrooms and associated cleanroom areas". In addition to the ...
Through Pharmaceutical Procurement and Supplier Qualification the quality of the components and the compliance to GMP is ensured.